According to Marketbeat, the five analysts covering Novavax, Inc. (NASDAQ:NVAX) have recommended on average to “Hold” the company’s shares. Two equities research experts have recommended that the business purchase the stock, and three have rated it with a hold rating. Brokerages who have rated the stock in the past year have set a 12-month price objective of $14.00 on average.
Recently, several research organisations have provided their opinions on NVAX. In a report released on Monday, TD Cowen raised their price objective for Novavax from $5.00 to $10.00 and recommended that investors “keep” the company. In a research note released on Monday, HC Wainwright maintained a “buy” rating on shares of Novavax and established a price objective of $19.00. In a report released on Friday, Bank of America improved its rating on shares of Novavax from “underperform” to “neutral” and increased its price target for the stock from $4.00 to $12.00. Ultimately, in a report on Friday, JPMorgan Chase & Co. raised its rating on shares of Novavax from “underweight” to “neutral.”
Related Article: AMC and GameStop rise 40% in premarket trading as the meme stock frenzy continues
Price Performance of Novavax
123,035,859 shares of Novavax were exchanged on Monday during trading, up $4.23 from the company’s average volume of 10,132,330. The stock ended the day at $13.11. Novavax has fluctuated between $3.53 and $13.97 during the past 52 weeks. The two-hundred-day simple moving average of the stock is $4.98, while the 50-day simple moving average is $4.73. With a $1.84 billion market value, the firm has a -4.18 P/E ratio and a 1.63 beta.
The most recent quarterly earnings data for Novavax (NASDAQ:NVAX) were released on Friday, May 10. The biopharmaceutical firm missed the average estimate of ($1.04) by ($0.01) and reported ($1.05) earnings per share for the quarter. In contrast to expert projections of $71.32 million, the company’s revenue for the quarter was $93.90 million. In the same time frame previous year, the company reported ($3.41) in profits per share. In comparison to the same quarter last year, Novavax’s revenue increased by 15.9%. Collectively, analysts covering stocks predict Novavax will report -0.82 earnings per share for the current year.
Read More: Deț vs. Centralized: Why Businesses Are Choosing Decentralization
Exchange of Institutions for Novavax
Recently, a number of significant investors have acquired and sold company shares. During the third quarter, Vanguard Group Inc. increased its holding in Novavax by 9.3%. After purchasing an extra 978,873 shares of the biopharmaceutical company’s stock during the most recent quarter, Vanguard Group Inc. now owns 11,551,476 shares of the company’s stock, valued at $83,633,000. In the fourth quarter, China Universal Asset Management Co. Ltd. increased its holdings in Novavax by 467.0%. After acquiring an extra 11,319 shares during the course of the quarter, China Universal Asset Management Co. Ltd. now holds 13,743 shares of the biopharmaceutical company’s stock, valued at $66,000. In the fourth quarter, Shah Capital Management increased its shares in Novavax by 22.9%. Shah Capital Management bought an additional 1,450,000 shares of the biopharmaceutical company’s stock in the most recent quarter, bringing its total holdings of the company’s stock to 7,780,756 shares, valued at $37,348,000. During the fourth quarter, SG Americas Securities LLC added to its holdings in Novavax, which were valued at around $824,000. Lastly, the Kantonalbank Zurcher During the third quarter, Zurich Cantonalbank increased its ownership in Novavax shares by 309.4%. Zurcher Kantonalbank After purchasing an additional 45,574 shares in the most recent quarter, Zurich Cantonalbank now owns 60,303 shares of the biopharmaceutical company’s stock, valued at $437,000. 53.04% of the company’s shares are held by hedge funds and institutional investors.
Also Read: Should You Buy YouTube Subscribers and Likes?
Overview of Novavax Company
A biotechnology business called Novavax, Inc. finds, develops, and markets vaccines to prevent dangerous infectious illnesses in order to promote better health. It provides a vaccination platform that boosts the immune response by combining nanoparticle technology, recombinant protein approach, and its own Matrix-M adjuvant.
-
Sen. Mark Warner vs. The Biden Administration: A Future Political Showdown?
As the 2024 presidential election looms on the horizon, the political landscape in the United States is poised for dramatic shifts and potential conflicts. Among the most anticipated developments is the emerging rivalry between Senator Mark Warner and the Biden administration. This article delves into the history, recent developments, and future implications of this political…
-
Minnesota Vikings – Historic Background and Modern Analysis
The Minnesota Vikings, a staple in the National Football League (NFL), boast a rich history and a passionate fan base. Since their inception in 1960, the Vikings have experienced highs and lows, producing legendary players, memorable moments, and a legacy of resilience. This article delves into the storied history of the Vikings, their evolution over…
-
Khyree Jackson Is A Rising Star in College Football
Khyree Jackson has rapidly become one of the most talked-about names in college football. His journey from high school standout to college sensation is an inspiring story of talent, perseverance, and dedication. This article delves into Jackson’s background, his achievements, and what the future holds for this promising athlete. Early Life and High School Career…
-
Ice Spice Mom – The Rising Star Behind the Viral Sensation
The music industry is constantly evolving, and every once in a while, a new star emerges that captures the hearts and minds of audiences worldwide. Recently, one such star has made waves with her unique style and compelling story: Ice Spice. While much has been said about Ice Spice herself, there’s a growing interest in…
-
Lindsay Hubbard Announces Her First Pregnancy: All You Need to Know
Lindsay Hubbard, the vibrant star of Bravo’s “Summer House,” has just announced some thrilling news—she is expecting her first child! Fans of the show and followers of Lindsay on social media have been eagerly awaiting updates from her life, and this announcement has certainly generated a wave of excitement. In this comprehensive article, we’ll dive…
-
Saks Fifth Avenue vs. Neiman Marcus: A Comprehensive Comparison
Saks Fifth Avenue and Neiman Marcus are two of the most iconic luxury department stores in the United States. Known for their high-end fashion, exquisite accessories, and exceptional customer service, both retailers have carved out significant niches in the luxury market. This article delves into the history, offerings, customer experiences, and recent developments of these…
Dwayne Paschke specializes in writing, management, development, design and Search Engine Optimization. Although he has worked for 8 years in the industry, he never found an ideal person to work with as a partner. Later, he found Sebastian Pearson, and they both found specific understanding between them. Both of them divided their tasks in this project and are running this venture successfully.